Operation and verification of a portable clinical analysis system

US10877019B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10877019-B2
Application numberUS-201815953671-A
CountryUS
Kind codeB2
Filing dateApr 16, 2018
Priority dateDec 17, 2012
Publication dateDec 29, 2020
Grant dateDec 29, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth's gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof.

First claim

Opening claim text (preview).

We claim: 1. A portable clinical system for in vitro analysis, the system comprising: a test device configured to perform an in vitro analytical test; and an analyzer comprising a port configured to receive the test device and a computing device configured to: determine spatial orientation and motion of the analyzer during a test cycle of the test device, generate a test cycle profile for the test cycle, wherein the generated test cycle profile indicates the determined spatial orientation and motion of the analyzer during the test cycle, compare the generated test cycle profile to a pre-established profile for the test device, determine whether the generated test cycle profile deviates from the pre-established profile, and at least one of (i) provide an alert prompting a user of the system to take corrective action and (ii) perform system maintenance, when the test cycle profile deviates from the pre-established profile. 2. The system of claim 1 , wherein the computing device is further configured to determine whether the system maintenance fails and to communicate a failure of the system maintenance to an electronic auditable system. 3. The system of claim 1 , wherein the computing device is further configured, when the generated test cycle profile deviates from the pre-established profile, to prevent reporting of a test result obtained from performance of the in vitro analytical test, and to provide an alert prompting the user of the system that the system maintenance is required. 4. The system of claim 3 , wherein the computing device is further configured to determine whether the system maintenance fails and to communicate a failure of the system maintenance to an electronic auditable system. 5. The system of claim 4 , wherein the electronic auditable system is configured to perform replacement of the analyzer when the failure of the system maintenance is communicated. 6. The system of claim 1 , wherein the computing device is further configured to communicate an operational status of the analyzer to a remote entity. 7. The system of claim 6 , wherein the remote entity comprises at least one of the user of the system, an entity responsible for integrity of the system, a distributor of the system, and a manufacturer of the system. 8. The system of claim 1 , wherein the determining whether the test cycle profile deviates from the pre-established profile comprises determining whether the test cycle profile deviates outside of an acceptable variation range from the pre-established profile for the test device. 9. The system of claim 8 , wherein the acceptable variation range is representative of expected variation from at least one of manufacturing variation and environmental variation. 10. The system of claim 1 , the computing device is further configured to collect acceleration data during the test cycle of the test device, wherein the acceleration data includes vibration characteristic of a electromechanical interaction between the test device and the analyzer during the test cycle, wherein the spatial orientation and the motion of the analyzer during the test cycle of the test device are determined based on the acceleration data, and wherein the test cycle profile indicates the determined spatial orientation and motion of the analyzer during the test cycle including the vibration characteristic of the electromechanical interaction between the test device and the analyzer during the test cycle. 11. A method comprising: initiating, by an analyzer, a test cycle of a test device to perform an in vitro analytical test on a sample; determining, by the analyzer, a spatial orientation and motion of the analyzer during the test cycle of the test device; generating, by the analyzer, a test cycle profile for the test cycle, wherein the generated test cycle profile indicates the determined spatial orientation and motion of the analyzer during the test cycle; comparing, by the analyzer, the generated test cycle profile to a pre-established profile for the test device; determining, by the analyzer, whether the generated test cycle profile deviates from the pre-established profile; and at least one of (i) providing, by the analyzer, an alert prompting a user of the test device to take corrective action or (ii) performing, by the analyzer, system maintenance, when the generated test cycle profile deviates from the pre-established profile. 12. The method of claim 11 , further comprising, when the system maintenance fails, using a computing device to communicate a failure of the system maintenance to an electronic auditable system. 13. The method of claim 11 , further comprising when the generated test cycle profile deviates from the pre-established profile, to prevent reporting of a test result obtained from performance of the in vitro analytical test, and to provide an alert prompting the user of the system that the system maintenance is required. 14. The method of claim 11 , wherein the determining whether the test cycle profile deviates from the pre-established profile comprises determining whether the test cycle profile deviates outside of an acceptable variation range from the pre-established profile for the test device. 15. The method of claim 14 , wherein the acceptable variation range is representative of expected variation from at least one of manufacturing variation and environmental variation. 16. The method of claim 11 , further comprising collecting, by the analyzer, acceleration data during the test cycle of the test device, wherein the acceleration data includes vibration characteristic of a electromechanical interaction between the test device and the analyzer during the test cycle, wherein the spatial orientation and the motion of the analyzer during the test cycle of the test device are determined based on the acceleration data, and wherein the test cycle profile indicates the determined spatial orientation and motion of the analyzer during the test cycle including the vibration characteristic of the electromechanical interaction between the test device and the analyzer during the test cycle.

Assignees

Inventors

Classifications

  • Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply · CPC title

  • G01N33/48Primary

    Biological material, e.g. blood, urine (G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M11/02) · CPC title

  • Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

  • Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10877019B2 cover?
The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth's gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof.
Who is the assignee on this patent?
Abbott Point Of Care Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/48785. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).